Fig. 1
From: ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
ARHGAP39 is overexpressed in breast cancer and associated with poor prognosis. A ARHGAP39 mRNA expression in pan-cancer based on the TCGA database. B Difference in ARHGAP39 mRNA expression level between breast cancer tissues and normal tissues in TCGA database. C Difference in ARHGAP39 protein expression between breast cancer and normal tissues in CPTAC database. D-F The correlation between ARHGAP39 mRNA expression level and molecular subtypes, pathological stages, and age. G-I The correlation between ARHGAP39 protein expression level and molecular subtypes, pathological stages, and age. (J-L) Kaplan–Meier plotter of the relapse free survival (RFS), overall survival (OS), and disease-specific survival (DSS) based on ARHGAP39 expression level of GSE1456